Ozempic Receives New Indications in Chronic Kidney Disease

Source link : https://www.newshealth.biz/health-news/ozempic-receives-new-indications-in-chronic-kidney-disease/

The US Food and Drug Administration (FDA) approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and cardiovascular death in adults with both type 2 diabetes and chronic kidney disease.  The approval is based on the phase 3b results of the international FLOW kidney outcomes trial, which involved more than 3500 […]

Author : News Health

Publish date : 2025-01-29 19:01:40

Copyright for syndicated content belongs to the linked Source.